These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31611440)

  • 1. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
    Turan G; Altun E; Aslan F; Kulahci O
    Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
    Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
    J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
    Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
    Kerschmann RL; McCalmont TH; LeBoit PE
    Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression.
    Pilch H; Weiss J; Heubner C; Heine M
    J Cutan Pathol; 1994 Dec; 21(6):507-13. PubMed ID: 7699117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: a clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies.
    Ruhoy SM; Guinee DG; Nuovo G
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):253-61. PubMed ID: 24717230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma.
    Carr RA; Mesiano D; Heffron C; Radonic T; Wiggins J; Tso S; Agrawal R; Cheung E; Slater DN; Nichols L; Craig P
    Pathology; 2023 Oct; 55(6):772-784. PubMed ID: 37573161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma.
    Dadfarnia T; Mohammed BS; Eltorky MA
    Ann Diagn Pathol; 2012 Jun; 16(3):171-6. PubMed ID: 22197541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.
    Bedir R; Güçer H; Şehitoğlu İ; Yurdakul C; Bağcı P; Üstüner P
    Balkan Med J; 2016 Mar; 33(2):121-7. PubMed ID: 27403379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
    Goldenhersh MA; Olsen TG
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.